Form 4: Director William Rastetter Receives DARE Stock Options

Director William H. Rastetter was granted 10,000 stock options in Dare Bioscience, Inc. as part of standard compensation.

Summary

• Director William H. Rastetter acquired 10,000 stock options in Dare Bioscience, Inc. (DARE).
• The options have an exercise price of $2.03 per share.
• The grant date is June 11, 2026, with an expiration date of June 11, 2036.
• The options vest in full on the earlier of the first anniversary of the grant date or the date of the next annual meeting of stockholders.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation that carries no significant signal regarding company performance.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• The grant results in potential future dilution for existing shareholders upon exercise.

Risks

• The value of the options is dependent on the future market performance of DARE common stock exceeding the $2.03 strike price.

Future Outlook

The options vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to continued service.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are a standard corporate governance practice in the biotechnology sector to incentivize board members and preserve cash reserves.

Comparison to Industry Standards

• The grant of stock options to directors is consistent with standard compensation packages for small-cap biotechnology companies.
• The vesting schedule tied to annual meetings is a common practice to ensure director retention through the governance cycle.

Stakeholder Impact

• Minor potential dilution for shareholders upon the eventual exercise of the options.

Next Steps

• Vesting of options on the earlier of June 11, 2027, or the next annual meeting of stockholders.

Key Dates

Keywords

Dare Bioscience, DARE, Form 4, Insider Trading, Stock Options, Director Compensation